The CD20 inhibitor Ocrevus (ocrelizumab) rapidly depletes immune B-cells in people with multiple sclerosis (MS), as expected, but ongoing treatment also leads to changes in immune T-cells, a new stud… [+3702 chars]
Ocrevus rapidly depletes B-cells, then alters T-cells in MS patients - Multiple Sclerosis News Today
Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a study found.
By:Steve Bryson, PhD
Source:Multiple Sclerosis News Today
Published:
Related News
Certain people should avoid gym supplement creatine due to worrying side effect - LADbible
Lots of people take creatine to boost their performance at the gym but certain people have been advised to avoid it due to a side effect
LADbible•Joe Harker
Two days of oatmeal can reduce cholesterol level - Medical Xpress
A short-term oat-based diet appears to be surprisingly effective at reducing the cholesterol level. This is indicated by a trial by the University of Bonn, which has now been published in Nature Communications. The participants suffered from a metabolic syndr…
Medical Xpress•Johannes Seiler
I Pursued Motherhood Despite Past Psychosis -- Then This Happened - HuffPost
HuffPost